Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Jayamas Medica Industri TbkISX:OMED +0.98%90 EV-to-FCF is 20.55 as of Jul. 16, 2026, which is 52% above its 10-year median of 13.50. GuruFocus rates ISX:OMED with a GF Score™ of 90/100 and a GF Value™ of Rp238.00 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 413 Medical Devices & Instruments companies, PT Jayamas Medica Industri Tbk ranks better than 56.42% on this metric.
The historical rank and industry rank for PT Jayamas Medica Industri Tbk's EV-to-FCF or its related term are showing as below:
ISX:OMED'
s EV-to-FCF Range Over the Past 10 Years
Min: -213.45 Med: 13.5 Max: 290.46
Current: 20.3
During the past 7 years, the highest EV-to-FCF of PT Jayamas Medica Industri Tbk was 290.46. The lowest was -213.45. And the median was 13.50.
ISX:OMED's EV-to-FCF is ranked better than 56.42% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.72
vs ISX:OMED: 20.30
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Jayamas Medica Industri Tbk (ISX:OMED) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Jayamas Medica Industri Tbk's PE Ratio (TTM) for today is calculated as:
PT Jayamas Medica Industri Tbk's share price for today is Rp206.00.
PT Jayamas Medica Industri Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp14.518.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Jayamas Medica Industri Tbk EV-to-FCF Related Terms
PT Jayamas Medica Industri Tbk EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Jayamas Medica Industri Tbk EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Jayamas Medica Industri Tbk's EV-to-FCF falls into.
PT Jayamas Medica Industri Tbk's current Enterprise Value is Rp4,469,371 Mil.
PT Jayamas Medica Industri Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp217,516 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Jayamas Medica Industri Tbk (ISX:OMED) has a EV-to-FCF of 20.55 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Jayamas Medica Industri Tbk and its competitors. This is 52% above median its historical median of 13.50. According to the industry distribution chart, PT Jayamas Medica Industri Tbk ranks #180 out of 413 companies in the Medical Devices & Instruments industry, placing it in the top 43.6%.
Is PT Jayamas Medica Industri Tbk's EV-to-FCF too high?
PT Jayamas Medica Industri Tbk's current EV-to-FCF of 20.55 is 52% above median its 10-year median of 13.50. The Medical Devices & Instruments industry median EV-to-FCF is 23.72. PT Jayamas Medica Industri Tbk's value of 20.55 is 13.4% below this industry median. Based on the distribution chart, PT Jayamas Medica Industri Tbk ranks #180 out of 413 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Jayamas Medica Industri Tbk ranks #180 out of 413 companies for EV-to-FCF. This puts PT Jayamas Medica Industri Tbk in the upper half of its industry. The industry median EV-to-FCF is 23.72. PT Jayamas Medica Industri Tbk's value of 20.55 is 13.4% below this benchmark. While the company's 10-year median is 13.50 vs. the industry median of 23.72, PT Jayamas Medica Industri Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.72, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Jayamas Medica Industri Tbk's current EV-to-FCF of 20.55 is 13.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Jayamas Medica Industri Tbk and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Jayamas Medica Industri Tbk's current EV-to-FCF is 20.55, which is 52% above median its own 10-year median of 13.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp238.00, compared to a current price of Rp206.00 — trading 13.4% below its estimated fair value. The current EV-to-FCF is 20.55, which is 52% above median its 10-year median of 13.50 and 13.4% below the Medical Devices & Instruments industry median of 23.72. PT Jayamas Medica Industri Tbk's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current EV-to-FCF is 20.55 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued.
The current stock price of Rp206.00 is trading 13.4% below its estimated GF Value™ of Rp238.00.
GuruFocus considers PT Jayamas Medica Industri Tbk to be Modestly Undervalued.
Key valuation signals for ISX:OMED:
EV-to-FCF: 20.55 (52% above median its 10-year median of 13.50)
GF Value™: Rp238.00 vs. price of Rp206.00 (13.4% below fair value)
Industry Position: 13.4% below the Medical Devices & Instruments median (#180 of 413)
No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Jayamas Medica Industri Tbk Business Description
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
90GF Score
Get the complete analysis for ISX:OMED
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:OMED has been successfully added to your 
